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Abstract  
Background: Tryptophan hydroxylase (TPH) is the rate-limiting enzyme in the synthesis of 
serotonin. We examined whether the TPH2 polymorphism -703G/T (rs4570625) is associated with 
aggressiveness and impulsivity, and the prevalence of psychiatric disorders, in a population-
representative sample. 
Methods: We used self and proxy reports on aggressive behaviour in the younger birth cohort of 
the longitudinal Estonian Children Personality, Behaviour and Health Study collected at age 25, 
and earlier collected impulsivity and related data of both ECPBHS cohorts. 
Results: The TT homozygous males reported less aggressive behaviour in the Life History of 
Aggression interview at age 25. They also had significantly lower scores in Illinois Bully Scale 
peer reports, and less ADHD symptoms rated by teachers both at ages 9 and 15. The TT 
homozygotes of both sexes had the lowest Maladaptive Impulsivity at ages 18 and 25, and the 
highest Adaptive Impulsivity at age 25. The TT homozygotes also had low depressiveness and 
trait anxiety by age 25, and the odds ratio for the prevalence of anxiety disorders was 9.38 for the 
G-allele carriers. 
Limitations: The main limitation of the study is the naturally occurring low number of subjects 
with the TT genotype. 
Conclusions: Subjects with the TPH2 rs4570625 TT genotype, especially males, exhibit less 
aggression and a favourable impulsivity profile, and develop anxiety disorders by young adulthood 
less often. 
 
 
1. Background 
Tryptophan hydroxylase (TPH) is the rate-limiting enzyme in the synthesis of serotonin. The role 
of the serotonergic system in regulating emotions, including aggressiveness is relatively well 
established (e.g., Bortolato et al., 2013; Lesch et al., 2012; Miczek et al., 2015). However, there is 
no simple explanation how alterations in serotonergic homeostasis lead to different types of 
psychopathology, or other- or self-directed aggressive behaviour. Therefore, additional 
information about the role of naturally existing variations in the serotonin system, including 
genetic variation, in emotion regulation and aggressive traits is crucial for understanding the 
underlying neurobiology. 
There are two isoenzymes of TPH in humans, TPH1 and TPH2, the latter being predominantly 
expressed in the brain (Carkaci-Salli et al., 2011; Walther et al., 2003). Variations in genes 
encoding both TPH-s have been linked to emotion regulation and aggression-related traits 
(Bortolato et al., 2013; Waider et al., 2011), including the potentially functional rs4570625 SNP 
in the TPH2 gene that leads to G to T base substitution in the promoter region at position -703. 
The functionality of this polymorphism still requires establishment: Two studies have found 
differences in gene expression in haplotypes containing the -703G/T (Chen et al., 2008; Lin et al., 
2007), but Scheuch et al. (2007) found no G/T difference in promoter activity. Nevertheless, in 
studies on brain and behaviour, the T-allele of the -703G/T polymorphism has been described as 
a psychiatric risk allele as it is linked to biased amygdala responsiveness (Brown et al., 2005; Canli 
et al., 2005) and is overrepresented in cluster B and C personality disorders, as well as in both 
affective and anxiety disorders with a sample of patients with personality disorders (Gutknecht et 
al., 2007). The meta-analysis by Gao et al. (2012) found T-allele carriers at greater risk of affective 
disorders, and one report (Mandelli et al., 2012) has suggested higher sensitivity to stressful life 
events in this genotype. In some contrast, Gutknecht et al. (2007) linked the haplotype containing 
rs4570625 Gallele to higher TPQ Harm Avoidance and NEO Neuroticism in healthy adults, and 
Reuter et al. (2007a) found lower harm avoidance in TT homozygotes. The G-allele has been found 
transmitted more often to the children affected by ADHD (Walitza et al., 2005) and OCD (Mössner 
et al., 2006); GG homozygotes, both controls and ADHD patients, had altered prefrontal function 
during response inhibition task (Baehne et al., 2009). Furthermore, increased frequency of the 
Gallele was associated with suicide attempts in patients with major depression (Yoon and Kim, 
2009). Perez-Rodriguez et al. (2010) found evidence of the involvement of TPH2 in aggressiveness 
but they tested haplotypes that did not contain rs4570625. TPH2 -703G/T SNP may have important 
effect on susceptibility to suicidal behaviour in major depression. 
In case of the TPH2 G/T polymorphism, for practical reasons, carriers of the low frequency T-
allele have mostly been compared with the GG genotype. However, in our recent study (Lehto et 
al., 2015) the population-derived sample was large enough to allow the comparison of all 
genotypes separately. We found that the TT homozygotes differed significantly from other 
genotype groups: Specifically, TPH2 G-allele homozygotes and GT heterozygotes had similar 
personality profiles while the TT homozygotes had significantly lower Neuroticism, and higher 
Extraversion and Conscientiousness. 
Given the important role of serotonergic function in emotion regulation and aggressiveness, and 
the findings on TPH2 described above, we sought to test how the variation in TPH2 rs4570625 
affects aggressive behaviour and related traits, and prevalence of mood, anxiety and alcohol use 
disorders in a population-representative sample of young adults. 
 
2. Method 
2.1. Sample 
This study was carried out on the Estonian sample of the European Youth Heart Study (1998/99), 
which was subsequently incorporated into the longitudinal Estonian Children Personality 
Behaviour and Health Study (ECPBHS). The EYHS sample of the ECPBHS consists of two birth 
cohorts. Data on aggressive and antisocial behaviour, bullying and victimisation are currently 
available for the younger cohort only. Hence, most of the present analysis is focused on data of 
this cohort, but relevant measures of both cohorts were subject to analysis if available. The 
rationale and procedure of sample formation have been described elsewhere in detail (Harro et al., 
2001; Tomson et al., 2011). The total number of subjects in the first wave in 1998/99 was 1176; 
583 in the younger cohort (MAge=9.6 ± 0.5) and 593 in the older cohort (MAge=15.6 ± 0.6). The 
follow-up studies for the younger cohort took place in 2004 (n=483, MAge=15.3 ± 0.5), 2007 
(n=454, MAge=18.3 ±0.5) and 2014 (n=440, MAge=25.3 ± 0.5); for the older cohort, the follow-ups 
were in 2001 (n=449, including 62 additional subjects, MAge=18.4 ± 0.9) and 2008 (n=541, 
MAge=24.7 ± 0.7). The number of subjects with valid genotype and psychometric data is given in 
Table 1. All the subjects were of Caucasian origin. The study was approved by the Tartu University 
Ethics Review Committee on Human Research. 
 
2.2. Measures 
2.2.1. Illinois Bully Scale (IBS) 
Illinois Bully Scale is an 18-item scale with three subscales, Bully, Fight, and Victim, assessing 
the frequency of bullying behaviour, fighting, and victimization by peers (Espelage and Holt, 
2001). We used the conventional self-report and a version of the scale adopted to be filled in by 
classmates where we asked subjects to rate their peers (peer reports, mostly two raters per person; 
each rater also reported on two classmates as a rule). In both cases, we asked subjects to recall the 
times in primary school assessing the frequency of listed behaviours in 5-point scale ranging from 
“never” to “very often”. In case of peer ratings, subjects were shown the list of classmates and 
were asked to select the first one or two peers they remembered well. For this reason, the number 
of subjects for whom proxy reports were obtained is larger than the number of participants in this 
particular study wave. The list was narrowed gradually as reports were obtained, but when a 
subject could not make a decision, he/she was permitted to pick someone from the list of already 
rated peers. Averaged scores were used in case of more than one rating per subject. 
 
2.2.2. ADHD symptoms by teacher reports 
ADHD symptoms were assessed by teachers as described in Kiive et al. (2010) using the 
Hyperactivity Scale (Af Klinteberg and Oreland, 1995). The data of both birth cohorts for ages 15 
and 18 were combined, while for age 9, data were available for the younger birth cohort only 
(Table 1). 
 
2.2.3. Impulsivity self-reports 
Participants filled in the Adaptive and Maladaptive Impulsivity Scale (Laas et al., 2010; Paaver et 
al., 2008;) with subscales measuring Fast decision making and Excitement seeking (functional or 
adaptive impulsivity), and Disinhibition and Thoughtlessness (dysfunctional or maladaptive 
impulsivity). The data of both birth cohorts collected at ages 18 and 25 were combined (Table 1). 
 
2.2.4. Psychiatric interview at age 25 
Psychiatric assessment based on DSM-IV was carried out in both birth cohorts at age 25 (Table 1) 
by experienced clinical psychologists using the Mini-International Neuropsychiatric Interview 
(M.I.N.I.5.0.0; Sheehan et al., 1998; Estonian version: Shlik et al., 1999). We used lifetime 
prevalence of disorders in the analysis. 
 
2.2.5. Life History of Aggression interview 
The Life History of Aggression interview (LHA, Coccaro et al., 1997) was carried out in the 
younger birth cohort immediately after the M.I.N.I. interview to assess dimensions of aggression 
(Table 1). Items were scored only for the history of actual behaviour. LHA has three subscales: 
Aggression (temper tantrums, verbal aggression, indirect aggression, non-specific fighting, and 
physical assault against people); Consequences/Antisocial Behaviour (school disciplinary 
problems, problems with supervisors, antisocial behaviour not resulting in police involvement, and 
antisocial behaviour involving the police); and Self-Directed Aggression (self-injurious behaviour, 
and suicide attempts). Each item was rated on a 5-point scale, ranging from 0=No events to 
5=More events than can be counted. 
 
 
 
2.2.6. TPH2 rs4570625 genotyping 
Genomic DNA was extracted from whole blood samples using Qiagen QIAamp® DNA Blood 
Midi Kit. Genotyping for TPH2 G-703T (rs4570625) was performed as described in Lehto et al. 
(2015) with the Applied Biosystems ViiA™ 7 Real-Time PCR System using the TaqMan® Pre-
Designed SNP Genotyping Assay with Solis BioDyne 5× HOT FIREPol® Probe qPCR Mix Plus 
(ROX). All DNA samples were successfully genotyped. The genotype frequencies were in Hardy–
Weinberg equilibrium. The distribution of TPH2 genotype (Table 2) was in Hardy-Weinberg 
equilibrium and did not differ between birth cohorts (Fisher's Exact Test p=0.546) and. The 
frequency of the minor T-allele was 21.8%. 
 
2.3. Statistical analysis 
Subjects were analyzed by the TPH2 genotype groups. Due to genotype distribution (see Table 2), 
the group sizes were too unequal to rely on parametric statistical tests like analysis of variance, so 
we have reported the results based on nonparametric tests. (ANOVA-s were, however, conducted, 
and the results were similar to the outcome of nonparametric tests.) We have used the following 
nonparametric tests for the scores of Illinois Bully Scale, LHA interview, ADHD report, 
impulsiveness and depressiveness: Kruskal-Wallis (KW) test for comparing three or more groups, 
Mann-Whitney (MW) U-test for two-group comparison, and interaction terms by adjusted rank 
transform (ART) test by Leys and Schumann (2010). The results for KW and MW U-tests are 
presented as raw p-values, and for the ART test as Fstatistic, raw p-value and η2 as a measure of 
effect size. The tables contain main statistics for comparison of G-allele carriers with the TT 
genotype, and results for all three genotype groups are presented for illustrative purposes and 
justification of combining all G-allele carriers against the TT genotype. Statistical analysis of 
TPH2 genotype distribution by lifetime presence of affective and anxiety disorders was performed 
with Fisher's exact test; odds ratios (OR) with confidence intervals (CI) were calculated as a 
measure of effect size. Contrasts were calculated for significant model effects. Calculations were 
made with SPSS.16. Whiskers indicate 95% confidence intervals. It was impossible to compute 
regression models with multiple predictors due to low number of TT homozygotes and missing 
data of different variables. The analysis was based on a priori hypotheses, so we have reported 
results as not corrected for multiple comparisons; a comment on implications of that is included in 
Discussion. 
 
3. Results 
3.1. TPH2 genotype and aggressiveness in school by the Illinois Bully Scale 
A main effect of TPH2 genotype was found: peers had reported less victimization for the subjects 
with TT genotype (Table 3), the effect originating from males. In addition, male TT homozygotes 
had lower Fight scores (Fig. 1 and Table 3). Genotype × Sex interaction effect was significant only 
in case of the Fight subscale where male G-allele carriers scored significantly higher as compared 
to the TT males and all females (Fig. 1B, nonparametric ART test, F(1, 506)=9.74, p=0.002, 
ƞ2=0.019). We found no statistically significant genotype differences in the IBS self-reports 
although similar tendencies were present. 
 
3.2. TPH2 genotype and aggressiveness by the LHA interview  
Male TT homozygotes scored much lower in the LHA interview (Table 4, Fig. 2), both in 
Aggression and Antisocial Behaviour subscales. Further analysis revealed that items in the 
Aggression subscale yielding genotype differences in males were Non-specific fighting (MW U-
Test, G-allele carriers vs. TT genotype, p=0.039), Verbal aggression (p=0.031) and Indirect 
aggression (p=0.049), but not Temper tantrums (p=0.297) and Physical assault against people 
(p=0.316). In the Antisocial Behaviour subscale, only School disciplinary problems individually 
yielded  genotype differences in males  (p=0.033).  There was no significant association of  TPH2 
genotype with Self-directed aggression (SDA) (χ2=1.75, p=0.186); however there were no TT 
subjects with self-directed aggressive behaviour (G-allele + no SDA=367, G-allele + SDA=46, TT 
+ no SDA=14, TT + SDA=0). No genotype differences in the LHA score were found in females. 
 
  
  
3.3. TPH2 genotype, impulsiveness and ADHD symptoms 
TPH2 genotype was associated with both impulsiveness and hyperactivity symptoms. For these 
analyses data of both birth cohorts were available. TPH2 TT homozygotes had lower Maladaptive 
impulsivity (MI) and higher Adaptive impulsivity (AI) at both ages 18 and 25 (Fig. 3A and B). At 
age 18, differences were significant in the whole sample (Fig. 3A), and in females analyzed 
separately (MI: KW test p=0.002, MGG=33.8 ± 0.5 MGT=34.1 ± 0.6 MTT=30.3 ± 1.8; AI: KW test 
p=0.036, MGG=37.1 ± 0.5 MGT=36.4 ± 0.6 MTT=38.4 ± 1.9), while at age 25, genotype effects 
emerged only if males and females were combined. 
 TPH2 effect on teacher-rated ADHD symptoms was observable at younger age only. TPH2 × Sex 
interaction effect was present at the age of 9: Male TT heterozygotes had less hyperactivity 
symptoms while in females the trend was to the opposite (Fig. 4; data available only for the 
younger birth cohort; ART test G-allele vs. TT F(1486)=6.54, p=0.011, ƞ2=0.013). This was the 
case for both motor restlessness and concentration difficulties while analyzed separately (not 
shown). At ages 15 and 18, similar but statistically non-significant trends were detected, and there 
were no genotype differences in teacher-rated aggressive behaviour at any age. 
 
 
3.4. TPH2 genotype, and anxiety and affective disorders 
Only one subject with the TT genotype of the TPH2 rs4570625 polymorphism had met the criteria 
for anxiety disorders by age 25 so the TT homozygotes were 9 times less likely to have an anxiety 
disorder compared to G-allele carriers (Fig. 5; Fisher's Exact Test for G-allele vs. TT genotype, 
p=0.003, OR for G-allele 9.38, 95% CI (1.28–68.8)). There was no difference in genotype 
distribution for mood and substance use disorders analyzed separately (Fisher's Exact Test p=0.271 
and p=0.440, respectively). However, if combining the anxiety and mood disorders the TT subjects 
had significantly less affective/anxiety disorders (G-allele vs. TT genotype p=0.018, OR for G-
allele 2.57, 95% CI=1.13–5.88; G+/no disorder=581, G+/disorder=308, TT/no disorder=34, 
TT/disorder=7). These findings were consistent with genotypic differences in both depressiveness 
and anxiety self-reports at age 25: TT homozygotes had lower depressiveness as measured with 
MADRS (MG+=7.41 ± 0.19, MTT=5.24 ± 0.88; MW U-Test p=0.015) and lower scores of both 
Trait (MG+=38.8 ± 0.3, MTT=35.5 ± 1.6; p=0.011) and State anxiety (MG+=31.3 ± 0.3, MTT=29.3 ± 
1.4; p=0.045). The differences were however not statistically significant at earlier ages (data not 
shown). While the differences at the age of 25 appeared similar in both sexes, the genotype effect  
 on depressiveness and trait anxiety reached statistical significance only in males (depressiveness 
in males MG+=6.92 ± 0.28, MTT=4.48 ± 1.18; p=0.040, and females MG+=7.78 ± 0.26, MTT=6.05 
± 1.30; p=0.201; trait anxiety in males MG+=37.2 ± 0.4, MTT=33.9 ± 1.9; p=0.033, and females 
MG+=40.0 ± 0.5, MTT=37.3 ± 2.5; p=0.171). 
 
3.5. TPH2 genotype effects on anxiety and depressiveness in alcohol use disorder 
Interestingly, the TPH2 genotype effect on state anxiety and on depressiveness scores at age 25 
were more pronounced in subjects who had by that age experienced alcohol use disorder (Fig. 6A 
and B). Thus, statistically significant genotype × diagnosis interaction effects were found (state 
anxiety, F(2852)=5.53, p=0.004, ƞ2=0.013; depressiveness, F(2910)=4.77, p=0.009, ƞ2=0.010). 
The TPH2 effect on trait anxiety was similar but less clear (ART test F(2852)=2.47, p=0.086, 
ƞ2=0.006, in AUD group only KW test p=0.005). Nine males had the TT genotype and a record of 
alcohol use disorder, and the interactions in males were also statistically significant; as only two 
females had the TT genotype and history of alcohol use disorder the interaction was not separately 
analyzed. 
 
 4. Discussion 
Subjects with the low-frequency TT genotype of the TPH2 rs4570625 polymorphism differed 
significantly in various affect-related behaviours and traits by self- and proxy-reports and by 
psychiatric interviews. They had less aggressiveness, victimization, ADHD symptoms, 
impulsiveness, depressiveness and anxiety, and were less likely to correspond to diagnostic criteria 
of anxiety disorders as compared to G-allele carriers. The differences were more prominent in 
males, especially with regard to aggressive traits in childhood and in young adulthood. 
Previous findings on the TPH2 −703 G/T polymorphism have not been consistent with regard to 
which allele has been associated with the outcomes considered favourable. Either allele has been 
reported as the risk allele for different psychiatric disorders or disadvantages (e.g., Gao et al., 2012; 
Gutknecht et al., 2007; Mössner et al., 2006; Walitza et al., 2005; Yoon and Kim, 2009). Owing 
to the lower prevalence of the Tallele, the T-allele homozygotes and GT heterozygotes have been 
combined in these studies. Here using a sample highly representative of a population we could 
observe that while some differences were found between GG homozygotes and GT heterozygotes, 
these were minor, but the TT homozygotes differed with regard to many measures, suggestive of 
their better mental health. The neurobiological implications of this polymorphism are not entirely 
clear but the T-allele has been suggested to relate to hyperfunction of tryptophan hydroxylase 
(Chen et al., 2008; Lin et al., 2007). If this were true, serotonin levels could be higher particularly 
in the TT homozygotes, and this could well be associated with low aggressiveness, anxiety and 
depressiveness. Animal studies (Kriegebaum et al., 2010) have demonstrated that alterations in 
TPH2 function and synthesis of 5-HT are subject to potent compensatory mechanisms, and this 
could theoretically explain the minor effect of a single T-allele. 
Certain limitations need be considered. Until replicated in other samples, one should remain 
cautious about interpretations of the present findings: While the sample has its merits in 
representativeness to population and in data collection at distinct ages, the main limitation of the 
study is the naturally occurring low number of subjects with the TT genotype. This has also 
prevented any more stratified analysis: We could not compute regression models with multiple 
predictors due to low number of TT homozygotes or to examine gene × environment interactions 
to check if the T-homozygotes react differently to environmental adversities as the serotonergic 
system, in which TPH2 is a key player, has been shown to be environment-sensitive (e.g., Waider 
et al., 2011). Other components of the serotonin system could moderate the association: Chen et 
al. (2008) found that -703G/T exerts synergic effects with another upstream SNP -473A/T, and is 
in strong linkage disequilibrium with other SNP-s (Gutknecht et al., 2007; Walitza et al., 2005) 
that could have a role in emotion regulation; furthermore, TPH2 has additive effects with the 5-
HTT (Canli et al., 2008; Herrmann et al., 2007; Lehto et al., 2015), but all this can be examined 
together with the TPH2 -703G/T TT homozygocity only in very large samples. Finally, we have 
not corrected the results for multiple comparisons as our study was based on a priori hypotheses. 
However, there was a number of results that would withstand the strict Bonferroni correction 
(0.05/8=0.006 for Illinois Bully Scale peer and self-reports, ADHD, impulsivity, Life History of 
Aggression, psychiatric interview, anxiety and depressiveness scores), e.g., the genotype effects 
on IBS Victim and Fight scores, maladaptive impulsivity at age 18, the prevalence of anxiety 
disorders, and G ×AUD effect on anxiety scores. 
Aggressiveness and impulsivity are often related to substance use (e.g., Cho et al., 2014) that in 
our sample is highly represented by alcohol abuse. We did not find any difference between TPH2 
-703G/T genotypes in the prevalence of alcohol use disorder. Instead, we found lower prevalence 
of anxiety disorders and lower scores of anxiety and depressiveness in the TT homozygotes, and 
exploring further we discovered that the lowest anxiety and depressiveness were reported by the 
TT homozygotes if they had a history of alcohol use disorder. The very small number of subjects 
involved prevents making any strong conclusions, but one could wonder about the potential 
mechanism behind this interaction. While alcohol can elicit a variety of subjectively pleasurable 
effects (Zeiger et al., 2012) long-term alcohol abuse increases anxiety and lowers mood (e.g., Falk 
et al., 2008). The acute anxiolytic and mood enhancing effect of alcohol results partly from 
increased serotonin (5-HT) turnover while chronic alcohol use is associated with decreased 5-HT 
turnover (Heinz et al., 2006; Lovinger, 1997;). Our rather young subjects were predominantly 
alcohol abusers, not dependent on alcohol, and one could speculate that in the subjects with two 
copies of the T-allele, suggestively linked to enhanced 5-HT synthesis (Lin et al., 2007), the 
emergence harmful effects of alcohol may be delayed. 
The TPH2-703G/T genotype effects were clearly more prominent in males. Sex differences have 
been reported before by Armbruster et al. (2010) who found that male T-allele carriers exhibited 
stronger startle responses compared to male GG homozygotes while in young women this effect 
appeared to be reversed. Overall, aggressive traits are more pronounced in males for evolutionary 
reasons (Archer, 2004), but why this relates to the TPH2 genotype remains to be elucidated. 
Similarly, thought-provoking is what could be the disadvantages brought about by the T-allele as 
it is the less frequent allele despite of the large positive differences in mental health of the TT 
homozygotes. The frequency of the T-allele in our sample (21.8%) was similar to other Caucasian 
non-patient samples ranging from 18% to 23% (Gutknecht et al., 2007; Zhou et al., 2005). Are the 
TT homozygotes too “nice”, lacking aggressiveness-related assertiveness? It is however possible 
that the favourable trait profile fades away with aging: Age dependent effects were reported by 
Armbruster et al. (2010) who found that genotype differences in startle responses emerged only in 
the sample of young adults, not in children or older adults. Cohort-specific effects have previously 
been reported: Reuter et al. (2007b) found that in their older cohort, females GG homozygotes 
started smoking earlier while in the younger cohort, smoking was initiated earlier by males GG 
homozygotes. While our two birth cohorts have revealed the existence of significant genotype by 
birth cohort interactions relevant to serotonergic neurotransmission (Vaht et al., 2015, 2014), the 
associations of aggressiveness and other traits with the TPH2-703G/T genotype appeared similar 
in the two independent cohorts. 
In conclusion, a low aggression and anxiety profile was found in the homozygotes for the minor 
T-allele of the TPH2 rs4570625. This is in line with the notion that higher serotonergic function 
inhibits aggressiveness and reduces anxiety, but indirectly suggests that at the level tryptophan 
hydroxylase genotype single alleles may have limited effect. 
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